These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

157 related items for PubMed ID: 37930206

  • 21. Clozapine-associated neutropenic enterocolitis.
    Beck DA, Miller DD.
    Ann Clin Psychiatry; 1994 Sep; 6(3):185-8. PubMed ID: 7881499
    [Abstract] [Full Text] [Related]

  • 22. Agranulocytosis and neutropenia with typical and atypical neuroleptics.
    Hong X, Wang X.
    Am J Psychiatry; 2001 Oct; 158(10):1736-7. PubMed ID: 11579015
    [No Abstract] [Full Text] [Related]

  • 23. [Retrospective study of clozapine use in Ile-de-France].
    Hiltgen S, Mantelet S, Pinabel F, Enjaume F.
    Encephale; 2006 Oct; 32(5 Pt 1):688-96. PubMed ID: 17099592
    [Abstract] [Full Text] [Related]

  • 24. Clozapine-induced agranulocytosis and leukopenia: Incidence, associated factors, and rate of hematologic adverse-effects monitoring in psychiatric out-patient services in Thailand.
    Tunsirimas N, Pariwatcharakul P, Choovanichvong S, Ratta-Apha W.
    Asian J Psychiatr; 2019 Mar; 41():13-16. PubMed ID: 30856469
    [Abstract] [Full Text] [Related]

  • 25. Lithium and clozapine rechallenge: a retrospective case analysis.
    Kanaan RA, Kerwin RW.
    J Clin Psychiatry; 2006 May; 67(5):756-60. PubMed ID: 16841625
    [Abstract] [Full Text] [Related]

  • 26. Clozapine rechallenge or continuation despite neutropenia or agranulocytosis using colony-stimulating factor: A systematic review.
    Corbeil O, Béchard L, Fournier É, Plante M, Thivierge MA, Lafrenière CÉ, Huot-Lavoie M, Brodeur S, Essiambre AM, Roy MA, Demers MF.
    J Psychopharmacol; 2023 Apr; 37(4):370-377. PubMed ID: 36794520
    [Abstract] [Full Text] [Related]

  • 27. Clozapine-Associated Agranulocytosis Treatment With Granulocyte Colony-Stimulating Factor/Granulocyte-Macrophage Colony-Stimulating Factor: A Systematic Review.
    Lally J, Malik S, Whiskey E, Taylor DM, Gaughran FP, Krivoy A, Flanagan RJ, Mijovic A, MacCabe JH.
    J Clin Psychopharmacol; 2017 Aug; 37(4):441-446. PubMed ID: 28437295
    [Abstract] [Full Text] [Related]

  • 28. The Effect of Clozapine on Hematological Indices: A 1-Year Follow-Up Study.
    Lee J, Takeuchi H, Fervaha G, Powell V, Bhaloo A, Bies R, Remington G.
    J Clin Psychopharmacol; 2015 Oct; 35(5):510-6. PubMed ID: 26267420
    [Abstract] [Full Text] [Related]

  • 29. Clozapine, agranulocytosis, and benign ethnic neutropenia.
    Rajagopal S.
    Postgrad Med J; 2005 Sep; 81(959):545-6. PubMed ID: 16143678
    [No Abstract] [Full Text] [Related]

  • 30. Use of cytokines in clozapine-induced agranulocytosis.
    Chin-Yee I, Bezchlibnyk-Butler K, Wong L.
    Can J Psychiatry; 1996 Jun; 41(5):280-4. PubMed ID: 8793147
    [Abstract] [Full Text] [Related]

  • 31. Long-term treatment with clozapine and other antipsychotic drugs and the risk of haematological malignancies in people with schizophrenia: a nationwide case-control and cohort study in Finland.
    Tiihonen J, Tanskanen A, Bell JS, Dawson JL, Kataja V, Taipale H.
    Lancet Psychiatry; 2022 May; 9(5):353-362. PubMed ID: 35334224
    [Abstract] [Full Text] [Related]

  • 32. Active monitoring of 12,760 clozapine recipients in the UK and Ireland. Beyond pharmacovigilance.
    Munro J, O'Sullivan D, Andrews C, Arana A, Mortimer A, Kerwin R.
    Br J Psychiatry; 1999 Dec; 175():576-80. PubMed ID: 10789357
    [Abstract] [Full Text] [Related]

  • 33. As-Required Filgrastim for Late-Onset Neutropenia Complicating Long-Term Clozapine Treatment: a Case Report.
    Chan KSW, Lai NBW, Wong MMC, Pang PF.
    East Asian Arch Psychiatry; 2023 Mar; 33(1):28-31. PubMed ID: 36991553
    [Abstract] [Full Text] [Related]

  • 34. The prevalence of agranulocytosis and related death in clozapine-treated patients: a comprehensive meta-analysis of observational studies.
    Li XH, Zhong XM, Lu L, Zheng W, Wang SB, Rao WW, Wang S, Ng CH, Ungvari GS, Wang G, Xiang YT.
    Psychol Med; 2020 Mar; 50(4):583-594. PubMed ID: 30857568
    [Abstract] [Full Text] [Related]

  • 35. Long-term combination treatment with clozapine and filgrastim in patients with clozapine-induced agranulocytosis.
    Hägg S, Rosenius S, Spigset O.
    Int Clin Psychopharmacol; 2003 May; 18(3):173-4. PubMed ID: 12702898
    [Abstract] [Full Text] [Related]

  • 36. [A case of neutropenia and agranulocytosis induced by clozapine. The importance of a drug surveillance program for their early detection].
    Alfaro J, Berdichevsky E, Conte G, Tellez C.
    Rev Med Chil; 1994 Jun; 122(6):694-8. PubMed ID: 7732216
    [Abstract] [Full Text] [Related]

  • 37. Clozapine-induced transient white blood count disorders.
    Hummer M, Kurz M, Barnas C, Saria A, Fleischhacker WW.
    J Clin Psychiatry; 1994 Oct; 55(10):429-32. PubMed ID: 7961519
    [Abstract] [Full Text] [Related]

  • 38. Absolute Agranulocytosis After 9 Weeks of Clozapine 25 mg Daily.
    Friedman JH.
    Clin Neuropharmacol; 1994 Oct; 45(1):9-10. PubMed ID: 35029864
    [Abstract] [Full Text] [Related]

  • 39. Effects of the clozapine national registry system on incidence of deaths related to agranulocytosis.
    Honigfeld G.
    Psychiatr Serv; 1996 Jan; 47(1):52-6. PubMed ID: 8925346
    [Abstract] [Full Text] [Related]

  • 40. Meta-analysis examining the epidemiology of clozapine-associated neutropenia.
    Myles N, Myles H, Xia S, Large M, Kisely S, Galletly C, Bird R, Siskind D.
    Acta Psychiatr Scand; 2018 Aug; 138(2):101-109. PubMed ID: 29786829
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.